Scientists test CBD-Infused heart pill in first human trial
NCT ID NCT06615284
Summary
This early-stage study aimed to check if a new combination drug called Atorvo+™ is safe for people. Atorvo+™ mixes a standard cholesterol-lowering medication (atorvastatin) with CBD. Researchers gave it to 24 healthy adults for 28 days to monitor for side effects and see how the body processes it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network
Melbourne, Australia
Conditions
Explore the condition pages connected to this study.